Latest News

Domain Therapeutics signs GPCR licensing agreement with Alkermes

Biopharmaceutical company Domain Therapeutics has signed a licensing agreement for its G-protein-coupled receptors (GPCR) BioSens-All technology with Ireland-based Alkermes....

Domain Therapeutics signs GPCR licensing agreement with Alkermes

Melbourne scientists develop first therapeutic dental vaccine

Melbourne scientists develop first therapeutic dental vaccine

Novimmune and Genentech enter exclusive licence agreement for rheumatoid arthritis drug

Novimmune and Genentech enter exclusive licence agreement for rheumatoid arthritis drug

Takeda to invest more than €100m in manufacturing plant for dengue vaccine in Germany

Takeda Pharmaceuticals has announced plans to invest more than €100m to build a new manufacturing plant for its dengue vaccine candidate in Singen, Germany....

Takeda to invest more than €100m in manufacturing plant for dengue vaccine in Germany

Pfizer drops €400m expansion plans of Grange Castle plant in Ireland

US drugmaker Pfizer has reportedly cancelled a planned €400m expansion of its plant at Grange Castle in Clondalkin, Dublin,...

Pfizer drops €400m expansion plans of Grange Castle plant in Ireland

Arrow Generiques signs agreement to purchase selects assets in France from Teva

Arrow Generiques, the French unit of Aurobindo Pharma, has signed an agreement to purchase select commercial products in France from...

Arrow Generiques signs agreement to purchase selects assets in France from Teva

Neovacs and 3P Biopharmaceuticals partner to manufacture IFNa

French company Neovacs and Spanish-based 3P Biopharmaceuticals have collaborated to manufacture interferon alpha (IFNα)....

Neovacs and 3P Biopharmaceuticals partner to manufacture IFNa

Teva receives European Commission approval for Trisenox indication extension

Teva Pharmaceutical Industries has obtained approval from the European Commission for an indication extension of Trisenox (arsenic trioxide)....

Teva receives European Commission approval for Trisenox indication extension

Deals this week: Incyte Corporation, Orexigen Therapeutics Ireland, Mitsubishi Tanabe Pharma Corporation

US-based biopharmaceutical company Incyte Corporation has entered a distribution agreement for the commercialisation of its drug named Iclusig (ponatinib) in Greece with GENESIS...

Deals this week: Incyte Corporation, Orexigen Therapeutics Ireland, Mitsubishi Tanabe Pharma Corporation

M&As this week: CiToxLAB, Sichuan Kelun Pharma

French-based pre-clinical services provider CiToxLAB Group has announced that it has acquired a pre-clinical contract research company known as...

M&As this week: CiToxLAB, Sichuan Kelun Pharma

Haiti launches cholera vaccination campaign

Haiti has launched an emergency cholera vaccination campaign, under which more than 800,000 affected by Hurricane Matthew last month will be...

Haiti launches cholera vaccination campaign

University of Adelaide researchers test drug that promises to prevent pre-term birth

Researchers at the University of Adelaide have conducted a successful drug test that shows early promises of preventing pre-term...

University of Adelaide researchers test drug that promises to prevent pre-term birth

Teva receives approval for generic Tribenzor in US

Teva Pharmaceutical Industries has secured approval for generic Tribenzor (olmesartan medoxomil, amlodipine and hydrochlorothiazide) tablets in the US and is in the last stages of launch preparation....

Teva receives approval for generic Tribenzor in US

NICE recommends treatment with 60mg of ticagrelor in post-heart attack patients

AstraZeneca has announced that National Institute of Health and Care Excellence (NICE) has published a Final Appraisal Determination (FAD) recommending 60mg of ticagrelor with aspirin...

NICE recommends treatment with 60mg of ticagrelor in post-heart attack patients

MHRA grants US patients with one form of blood cancer access to investigational medicine

The Medicines Healthcare Products and Regulatory Agency (MHRA) has granted US-based patients with one form of blood cancer access to the investigational medicine, nivolumab, through the...

MHRA grants US patients with one form of blood cancer access to investigational medicine

Deals this week: Asymchem Laboratories, Xbrane Biopharma, Biohaven Pharmaceutical Holding Company

Chinese-based contract manufacturing company Asymchem Laboratories has announced the issue of shares of its common stock in an initial public offering...

Deals this week: Asymchem Laboratories, Xbrane Biopharma, Biohaven Pharmaceutical Holding Company

M&As this week: Canopy Growth Corporation, Novogen, Karo Pharma

Canadian cannabis company Canopy Growth Corporation has completed the acquisition of medical cannabis company Vert...

M&As this week: Canopy Growth Corporation, Novogen, Karo Pharma

UK team of health experts deployed to help control global disease outbreaks

A UK team of health experts comprising clinicians, scientists and academicians will be deployed to respond to requests from countries worldwide to help control disease outbreaks within 48 hours....

UK team of health experts deployed to help control global disease outbreaks

Novartis LEE011 receives FDA Priority Review for first-line treatment of HR+ / HER2- advanced breast cancer

The US Food and Drug Administration (FDA) has accepted Novartis' New Drug Application (NDA) for filing and granted Priority Review for LEE011 (ribociclib) as first-line treatment of...

Novartis LEE011 receives FDA Priority Review for first-line treatment of HR+ / HER2- advanced breast cancer

Medivir to sell BioPhausia to Karo Pharma

Medivir has entered into an agreement to sell its subsidiary BioPhausia (Nordic Brands) to Karo Pharma for Skr908m ($100.9m)....

Medivir to sell BioPhausia to Karo Pharma

Deals this week: Nordic Nanovector, Myriad RBM, Relief Therapeutics

Nordic Nanovector and Heidelberg Pharma GmbH have entered a research agreement to develop novel treatment for...

Deals this week: Nordic Nanovector, Myriad RBM, Relief Therapeutics
cachename:Newscachekey:rd-137342983_-954009584_rd-1665407042_1857678299_rd-488908060_1460672566_ap1460672566_1857678299_1613048906